Previous product
Back to products
Vitrakvi (larotrectinib)
CHF18,200.00
Next product
Copiktra (duvelisib)
CHF18,546.42
Vizimpro (dacomitinib)
CHF3,120.00
Vizimpro (dacomitinib) is a medication used for the treatment of patients with metastatic NSCLC with EGFR exon 19 deletion or exon 21 L858R substitution mutations.
Reviews
There are no reviews yet.